TRANSCEND-T2D-1 Type 2 diabetes (readout: March 19, 2026)
Neither approach is universally right or wrong
( a ) Overall pathway schematic for relevant metabolites, indicating both labeled and unlabeled species that will be present in the livers
: , Lilly Novo Nordisk , Lilly 2025 1 Mounjaro Zepbound
These GLP-1 agonists can be a two-in-one solution for diabetes and weight loss, Robert Fontana, MD, a Michigan Medicine hepatologist said in an online interview, maybe a three-in-one solution if they prove to be safe and effective for metabolic associated steatohepatitis as well. When asked about the benefits observed in patients using GLP-1RA medications for conditions other than diabetes, the top five areas of improvement that physicians reported included weight loss (92 percent), positive effects on lipid profiles (57 percent), reduced cravings or dependency behaviors (56 percent), reduced blood pressure (48 percent), and reduced inflammation (46 percent)